How some commensal bacteria would exacerbate colorectal carcinogenesis?;Certaines bactéries de la flore commensale exacerberaient-elles la carcinogenèse colorectale ?

Medecine/Sciences

Volumn 32, Issue 2, 2016, Pages 175-182

  Raisch, Jennifer ^a,b   Dalmasso, Guillaume ^a   Bonnet, Richard ^a,c   Barnich, Nicolas ^a   Bonnet, Mathilde ^a   Bringer, Marie Agnès ^a,d  

^a CRNH Auvergne   (France)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^d UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BACTERIAL PHENOMENA AND FUNCTIONS; BACTEROIDES FRAGILIS; CARCINOGENESIS; COLORECTAL TUMOR; DISEASE COURSE; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; GASTROINTESTINAL TRACT; HUMAN; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SYMBIOSIS;

ANIMALS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BACTEROIDES FRAGILIS; CARCINOGENESIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; GASTROINTESTINAL TRACT; HUMANS; SYMBIOSIS;

EID: 84962518072     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20163202011     Document Type: Review

References (36)

1. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet 2014; 383: 1490502.
2. Sommer F, Backhed F. The gut microbiotamasters of host development and physiology. Nat Rev Microbiol 2013; 11: 22738.
3. Jobin C. Microbiome: un nouveau facteur de risque de cancer colorectal ? Med Sci (Paris) 2013; 29: 5825.
4. Normand S, Secher T, Chamaillard M. La dysbiose, une nouvelle entité en médecine ? Med Sci (Paris) 2013; 29: 5869.
5. AllenVercoe E, Jobin C. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett 2014; 162: 5461.
6. Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative profiling of colorectal cancerassociated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One 2015; 10: e0119462.
7. Zackular JP, Baxter NT, Iverson KD, et al. The gut microbiome modulates colon tumorigenesis. MBio 2013; 4: e0069213.
8. Boleij A, Hechenbleikner EM, Goodwin AC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015; 60: 20815.
9. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 101622.
10. Rhee KJ, Wu S, Wu X, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wildtype C57BL/6 mice. Infect Immun 2009; 77: 170818.
11. Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces cMyc expression and cellular proliferation. Gastroenterology 2003; 124: 392400.
12. Kim JM, Lee JY, Kim YJ. Inhibition of apoptosis in Bacteroides fragilis enterotoxinstimulated intestinal epithelial cells through the induction of cIAP2. Eur J Immunol 2008; 38: 21909.
13. Goodwin AC, Destefano Shields CE, Wu S, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilisinduced colon tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 153549.
14. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 2928.
15. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumorimmune microenvironment. Cell Host Microbe 2013; 14: 20715.
16. Shenker BJ, Datar S. Fusobacterium nucleatum inhibits human Tcell activation by arresting cells in the midG1 phase of the cell cycle. Infect Immun 1995; 63: 48306.
17. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating Ecadherin/ betacatenin signaling via its FadA adhesin. Cell Host Microbe 2013; 14: 195206.
18. Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 2015; 42: 34455.
19. Arthur JC, PerezChanona E, Muhlbauer M, et al. Intestinal inflammation targets cancerinducing activity of the microbiota. Science 2012; 338: 1203.
20. Bonnet M, Buc E, Sauvanet P, et al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res 2014; 20: 85967.
21. Feng Q, Liang S, Jia H, et al. Gut microbiome development along the colorectal adenomacarcinoma sequence. Nat Commun 2015; 6: 6528.
22. Raisch J, Buc E, Bonnet M, et al. Colon cancerassociated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol 2014; 20: 656072.
23. Maddocks OD, Short AJ, Donnenberg MS, et al. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One 2009; 4: e5517.
24. ProrokHamon M, Friswell MK, Alswied A, et al. Colonic mucosaassociated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 2014; 63: 76170.
25. Lemercier C. Les infections bactériennes vues du génome eucaryote: cassures doublebrin, inflammation et cancer. Med Sci (Paris) 2014; 30: 75864.
26. Arthur JC, Gharaibeh RZ, Muhlbauer M, et al. Microbial genomic analysis reveals the essential role of inflammation in bacteriainduced colorectal cancer. Nat Commun 2014; 5: 4724.
27. CuevasRamos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 2010; 107: 1153742.
28. Vizcaino MI, Crawford JM. The colibactin warhead crosslinks DNA. Nat Chem 2015; 7: 4117.
29. Cougnoux A, Dalmasso G, Martinez R, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescenceassociated secretory phenotype. Gut 2014; 63: 193242.
30. Secher T, SambaLouaka A, Oswald E, Nougayrede JP. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS One 2013; 8: e77157.
31. Cougnoux A, Delmas J, Gibold L, et al. Smallmolecule inhibitors prevent the genotoxic and protumoural effects induced by colibactinproducing bacteria. Gut 2015; pii: gutjnl2014307241.
32. Miraglia AG, Travaglione S, Meschini S, et al. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factorkappaB and Bcl2. Mol Biol Cell 2007; 18: 273544.
33. Maddocks OD, Scanlon KM, Donnenberg MS. An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. MBio 2013; 4: e0015213.
34. Raisch J, Rolhion N, Dubois A, et al. Intracellular colon cancerassociated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX2 expression. Lab Invest 2015; 95: 296307.
35. Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342: 96770.
36. Sobhani I. Helicobacter pylori et cancer gastrique. Med Sci (Paris) 2004; 20: 4316.